Medicare Advantage plans in the United States continue to explode in popularity, now reaching over 30 million Americans, due to the broad appeal of supplemental benefits that can be offered by plans to enrollees. What started off as a core set of benefit offerings, including dental, vision, and over-the-counter medications, has recently been expanded by … Read more
In “Aggregated Precision Investment: Strengths, Weaknesses, and Potential Paths Forward,” Rebecca Nielsen, Brooke Zollinger, and Sarah Johnson from Leavitt Partners explore the feasibility of operationalizing an aggregated precision investment (API) model for social determinants of health (SDOH) interventions. The authors derive their findings from subject matter expert interviews, conversations with potential aggregators, and relevant secondary research. This article enumerates … Read more
Data science and digital health in clinical development and operations: impact, challenges, and calls to action for the drug development ecosystem In this paper, the Medicines Development Modernization Initiative discuss how three medicines development tools (MDTs) – artificial intelligence (AI) and machine learning (ML) algorithms, digital health tools (DHTs), and augmentation of randomized controlled trial … Read more
Leavitt Partners examined publicly available resources to determine the 340B Drug Pricing Program’s (340B) impact on drug prices charged by both covered entities and pharmaceutical manufacturers. To answer these questions, Leavitt Partners undertook a comprehensive literature review of publicly available governmental reports, peer-reviewed journal articles, white papers, news articles, and other publicly available sources to … Read more
Nonadherence to a prescribed medication regimen for patients with chronic pain is associated with overall lower health outcomes, including increased hospital admissions, costs, and morbidity (quantitative review here). Deviations in timing, dosage, frequency, or duration of medication—all components of noncompliance—can cause medical reactions, increased pain, and medication use disorders, and can ultimately lead to emergency care … Read more
As efforts continued at the beginning of 2022 to implement the No Surprises Act aimed at preventing surprise medical bills that patients are often unable to pay, the Kaiser Family Foundation published a report that estimates nearly one in 10 adults have medical debt, and that Americans’ total medical debt could be as high as $195 billion. … Read more
Salt Lake City, July 24, 2019—Today, Leavitt Partners released a new white paper, “Moving Forward Together: Opportunities to Improve Program Integrity in Medicaid Non-Emergency Medical Transportation.” This paper examines Medicaid’s non-emergency medical transportation (NEMT) benefit and makes specific recommendations on key actions federal and state policymakers can take to improve program integrity. The recommendations were … Read more
Salt Lake City, May 22, 2019—Today, Leavitt Partners released a white paper titled “No Evidence That ACO-Affiliated Hospitals are Narrowing Their PAC Networks.” This white paper details the findings from an analysis of Medicare claims data that was compared with Accountable Care Organization (ACO) affiliation data from Torch Insight™, a proprietary analytics platform and compendium … Read more
Salt Lake City, May 1, 2019—Today, Leavitt Partners released “The Medicaid ACO Landscape,” a white paper providing insight into the number, geographic dispersion, characteristics, and success of Medicaid ACOs as of the end of 2018. This snapshot of Medicaid ACOs was created using data from Torch Insight™, a proprietary analytics platform and compendium of health … Read more
